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ABSTRACT 
Background & Purpose:  
Controversy exists whether surgical treatment is influenced by insurance status. American studies 
suggest higher morbidity and decreased survival in uninsured patients with colorectal cancer (CRC). It 
remains elusive, however, whether these findings apply to European countries with mandatory, 
government-driven insurance systems. We aimed to analyze whether operative techniques, quality of 
surgery and complication rates differ among patients covered by statutory (SI) versus private (PI) 
healthcare insurance. 
Methods: 
Based on a prospective national surgical quality database, patients undergoing elective resection for 
CRC during 2007-2015 were identified. A propensity score match of eligible patients with SI and PI 
yielded 765 patients per group.  
Results:  
Hierarchical status of the operating surgeon differed substantially (p=0.001): Junior surgeons operated 
on >50% of patients with SI, whereas over 80% of patients with PI were operated by senior surgeons. 
Minimally-invasive techniques were used more frequently in patients with PI (p=0.001) and patients 
with SI undergoing colonic resection showed an increased conversion rate (OR 2.44). Median duration 
of surgery (p=0.001) and blood loss (p=0.002) were higher in patients with SI; however, length of 
hospital stay was equal. Neither the rate of positive resection margins nor the number of resected 
lymph nodes differed among groups. Complications & mortality occurred with similar frequencies for 
patients undergoing colon (p=0.140) and rectal (p=0.335) resection.  
Conclusion:  
The use of minimally invasive techniques was favored in patients with PI, however the quality of 
oncological resection was not affected by insurance status and only minor differences in perioperative 
complications observed. 
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INTRODUCTION 
Colorectal Cancer (CRC) remains the third most common reason of cancer-related deaths worldwide 
and the second most common in first-world countries1. Surgery constitutes the main treatment 
modality for CRC, if a curative treatment approach is chosen2,3.  
Various factors are known to influence perioperative outcomes and complications after oncological 
colorectal surgery, including extent of comorbidities, the caseload of the treating hospital as well as the 
experience of the individual surgeon4. What remains less well examined, however, is how outcomes 
depend on the level of healthcare insurance.  
Several studies analyzing the situation in the United States, where basic healthcare insurance is not 
mandatory, show different outcomes depending on insurance levels. A landmark study comprising 
64,304 American CRC patients demonstrated lower overall oncological survival in patients without 
private insurance (PI) and an increased level of comorbidities at time of first diagnosis5. Uninsured 
patients also present with cancerous lesions more often in a late and metastasized state6. Importantly, 
survival in these studies remained worse also after adjusting for comorbidities and covariates. 
Consistent with the above reports, patients undergoing surgery for CRC without insurance or 
Medicaid-coverage only showed an increased rate of emergent admissions with more frequent 
perioperative complications, increased rates of in-hospital deaths and higher postoperative morbidity7.  
These findings seem to hold true for oncological diseases in general. It was observed that uninsured 
patients present more frequently with advanced disease stages, especially in cancers which are 
potentially recognizable through screening8. A recent study confirmed that uninsured patients 
generally present with more complex disease stages in the emergency department9 and consequently 
more commonly need an emergency operation10. Furthermore, insurance status has also been shown 
to influence long-term outcomes after elective oncological surgery. A large cohort from the Nationwide 
Inpatient Sample database comprising patients with lung resection, esophagectomy, pancreatectomy 
and gastrectomy consistently reported increased mortality rates for un- or Medicaid-insured patients11. 
 
As most reports on the influence of insurance status are performed in the US healthcare system, it 
raises the question whether similar shortcomings exist in other parts of the world.  
Many countries, including European ones, have mandatory statutory healthcare insurance (SI), 
covering all medical necessary care. Patients may opt for additional PI, which provides certain benefits 
with respect to accommodations and amenities, treatment at private hospitals and the choice of the 
operating surgeon. Older reports show increased rates of non-oncological operations in patients with 
PI like appendectomies or cholecystectomies with a concomitant higher percentage of negative 
pathological specimens after appendectomies12,13. The influence of insurance status on outcomes for 
oncological surgery in Europe, however, remains elusive.  
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We therefore intended to examine whether patients with basic SI show impaired outcome after 
oncological surgery. Our hypothesis is that patients with SI receive an oncological operation of inferior 
technical quality compared to patients with PI, show differences in their perioperative course and 
suffer from higher perioperative morbidity. To test this hypothesis, we have queried our nation’s largest 
surgery quality database.  
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METHODS 
Database processing 
An extraction of the prospective, largest nationwide surgical quality control AQC database 
(Arbeitsgemeinschaft für Qualitätssicherung in der Chirurgie, Switzerland)14,15 was performed on the 
16th of May 2016, compromising data of 42’689 patients undergoing various surgical procedures 
performed between the 1st of January 2007 and 31st of December 2015. 
The database was filtered for patients with the main diagnoses colorectal cancer according to the 
current ICD-10-GM definitions (Version 2016), yielding 5343 patients in which a malignant neoplasm 
of the colorectal tract was the reason for hospitalization. In a second step, patients undergoing a 
colonic or rectal resection for their malignant disease were selected based on the applied surgical 
codes16 for partial/segmental colectomy (including hemicolectomy left/right), total colectomy and rectal 
resection, resulting in 3624 eligible patients. Refer to supplementary information (Supp. Info. 1-3) for 
information how to assess the AQC database and the codes used for filtering. 
 
To acquire the most representative sample of patients undergoing elective colorectal surgery for CRC, 
remaining patients were then sequentially filtered for procedures labelled explicitly as planned & 
elective (in contrast to emergent procedure or unplanned), thereby excluding 1363 patients. 
Successively, patients were filtered and removed if a complication of a previous surgical intervention 
was indicated as reason for surgery (n=18), indication of age was missing, or age was below 18 years 
(n=1), duration of surgery was missing or indicated as <60minutes (n=36), indication of insurance 
class was not given (n=26), or ASA Score was missing (n=18). Duplicate entries were identified based 
on the data for age, date of surgery, ASA-Score, date of admission, date of discharge, length of 
surgery and insurance-class (n=28) and consequently removed.  
Propensity score matching 
The final number of 2134 patients, consisting of 1369 patients with SI and 765 patients with PI was 
then used to perform a 1:1 propensity score match for patiens with SI versus patients with PI based on 
age, ASA-score, gender and the location of the primary tumor (colon, sigmoid or rectum). This 
matched 765 patients with SI with the 765 patients with additional PI and represented the final 
database used for the analyses (Fig. 1, Supp. Info. 5) 
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Endpoints 
Due to considerable differences in the surgical procedure, patients undergoing colonic resection and 
patients undergoing rectal resection were separately analyzed. Patients with PI and SI in both groups 
were analyzed for differences in the level of experience of the operating surgeon, use of minimally-
invasive surgical (MIS) techniques, rate of conversions from MIS to an open surgical approach, 
frequencies of stoma formation, blood loss, duration of surgery and length of hospital stay. Rate of 
incomplete (R1/R2) resections as well as number of resected & invaded lymph nodes served as 
surrogate parameter of the quality of oncological resection. Morbidity and mortality were examined via 
frequencies & severity of recorded complications.  
Statistical analyses 
Continuous data are given as median +/- interquartile range (IQR). Wilcoxon’s rank sum test or 
Fisher’s exact test were used to compare medians, resp. odds in the baseline groups. Statistical 
significance was defined as p < 0.05. No adjustment for multiple testing was performed when 
assessing rates of complications. All database processing, statistical analyses, propensity score 
matching, and graphical representations were done using R (Version 3.4.3) / R-Studio (Version 
0.99.903) (Session Information: Supp. Info. 10).  
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RESULTS 
Patient characteristics 
After Propensity score matching, pre-existing differences in the distribution of gender, ASA-score, 
location of primary tumor and histological grade, were equalized, resulting in an even distribution of 
gender, comparable median age and ASA score levels between groups. The frequency of CRCs 
located in the colon, the sigmoid or the rectum did not differ among groups. Furthermore, no more 
difference was detected for levels of T-stage, N-stage, M-stage, L-stage, V-stage or histological 
grading, indicating an equal distribution of tumor stages in our patient cohort (Tab. 1).  
Surgical & hospitalization parameters 
With respect to the level of seniority of the operating surgeon, a clear difference was observed 
between patients with SI and patients with PI undergoing colon (p ≤ 0.001) as well as rectal resection 
(p ≤ 0.001). Junior or senior attending surgeons operated on >50% of patients with SI, whereas over 
80% of patients with PI were operated by either a chief surgeon or a non-house surgeon in private 
practice. Residents were listed as operating surgeon in 11.5% of patients with SI undergoing colonic 
resection, while rates of residents were negligible in SI patients undergoing rectal resection or 
operations of both kinds in PI patients (Fig. 2A, Supp. Info 6: information on hierarchical positions of 
surgeons). 
Regarding surgical technique, we found that traditional open operations were performed more 
frequently in patients with SI undergoing colon (OR: 1.79 [1.33-2.41], p ≤ 0.001) as well as rectal 
resection (OR: 1.43 [1.04-1.97], p ≤ 0.001), whereas robotic and laparoscopic surgery was used more 
frequently in patients with PI (Fig. 2B). While an elevated conversion rate of 30.7% among patients 
with SI versus 15.3% in patients with PI undergoing colon resection was observed (OR: 2.44 [1.34 – 
4.51], p = 0.002), no major difference was detected in patients undergoing rectal resection (Tab. 2). 
Diverting loop Ileostomies or colostomies was performed with equal frequencies regardless of 
insurance status for both operations (Tab. 2, Supp. Info 4).  
A difference was noted regarding the duration of surgery, with an average of 28 and 20 minutes longer 
median operative time for patients with SI undergoing colon and rectum resection respectively (Fig. 
2C). Similarly, patients with SI had a higher median amount of surgeon-recorded blood loss for both 
types of resection (Fig. 2D). No difference in the length of hospital stay was observed for both colon 
and rectal resections (Fig. 2E).  
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Parameters of oncological resection 
Positive resection margins were found in 3.8% in SI and 4.3% in PI patients undergoing colon 
resection and 3.9% and 4.3% of rectal resections respectively (Tab. 2). Similarly, no difference was 
detected when R1 and R2 resections were analyzed separately. Furthermore, neither the number of 
resected lymph nodes nor the number of lymph nodes testing positive for adenocarcinoma during 
histological analyses showed major difference among groups (Tab. 2).  
Complication Rates 
The grades of severity of intraoperative complications did not differ between patients with SI and PI for 
neither colon nor rectal resections (Tab. 3, Supp. Info. 7). No difference in the low recorded rates of 
individual intraoperative complication rates observed (Supp. Info. 8). 
Similarly, the overall occurrence of postoperative complications was similar for both operations among 
patients with SI and PI (Tab. 3). Furthermore, the severity of postoperative complications as assessed 
using the Clavien-Dindo score17,18 did not differ significantly for colon resections (p = 0.140, Tab. 3) 
and was also equal for patients undergoing rectal resection (p = 0.335, Tab. 3). A fatal complication 
was recorded in 3 patients with SI and 2 with PI. Considering specific postoperative complications, 
higher rates of pneumonia as well as wound healing disorders were recorded in patients with SI 
undergoing a colon resection compared to their matched PI counterparts (Tab. 3), while all other 
complications recorded, including surgery-related (anastomotic failure, wound infection/abscess, 
fascia dehiscence, seroma/hematoma, Tab. 3), cardiovascular, pulmonary, gastrointestinal, urogenital 
and infectious/others, showed comparable rates among the SI and PI patients for both operations 
(Supp. Info. 9). 
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DISCUSSION 
Inequalities in the quality of health care among patients with different racial, social or economic 
backgrounds should be absent in an ideal healthcare system. However, several studies analyzing the 
influence of insurance status on surgical outcomes in the United States have shown worse short-term 
and long-term outcomes for uninsured or Medicaid-insured patients with CRC7,19,20. A recent study in 
JAMA oncology confirmed these observations, showing that recent improvements in survival were 
almost exclusively limited to patients with private or Medicare Insurance, while survival of uninsured or 
Medicaid insured patients stagnated or even declined21. Those findings are concerning, given that 
approximatively 15% of adults in the US are uninsured, with clear differences according to racial 
background and level of education, leaving minorities and less-educated people with a higher risk of 
surgical complications and cancer-related death20. However, it remains elusive whether similar 
observations may be made in European countries with mandatory government health insurance.  
 
The present study was meant to test whether parameters of surgery, hospitalization and treatment 
related morbidity differ between patients covered by statutory basic insurance versus patients with 
additional private insurance in a European healthcare system. We applied a rigorous filtering algorithm 
to a large surgery quality control database and performed a consequent propensity score matching to 
acquire a meaningful and homogenous cohort of patients with basic SI and additional PI undergoing 
surgical resection of colon or rectal cancer.  
 
In a first step, the level of the operating surgeon was analyzed. As a hallmark of private insurance is 
that patients can choose the operating surgeon, it is not surprising that a clear shift towards surgeons 
with higher levels of experience was observed. The majority of PI patients was operated by surgeons 
in private practice, which reflects the fact that patients with private insurance can resort to private 
hospitals with a higher level of amenities, which are not accessible to patients with basic statutory 
insurance only. 
We furthermore observed that patients with PI were operated more frequently using minimally invasive 
techniques. This is in accordance with reports from the US healthcare system, which observed that 
uninsured patients are more likely to be operated with conventional open surgical techniques in 
contrast to patients with PI, which are operated more frequently using laparoscopy22. This might reflect 
the increased level of expertise of the operating surgeons, while additionally operations on private 
patients are normally not taught to junior staff or residents. Lastly, patients with private insurance have 
the possibility to choose the hospital of their choice, including private hospitals, which might have 
better infrastructure, e.g. more advanced equipment or systems for robotic surgery. Patients with 
statutory insurance are normally limited to receive treatment in the public hospital they were referred 
to. 
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The higher level of experience of operating surgeons is probably also reflected in shorter operation 
times as well as the lower reported blood loss of privately insured patients. Interestingly, despite 
higher blood loss, less experienced surgeons, longer operating times and more frequent open surgical 
approaches, no increase in the average length of hospital stay was observed in patients with SI.  
Additionally, the oncological quality of resection was not affected in our patient sample, as judged by 
the rate of R1 and R2 resections and the amount of retrieved and invaded lymph nodes. While shorter 
operation times and laparoscopic approaches might reduce the occurrence of certain perioperative 
complications and provide added patient comfort, the main goal of achieving radical oncologic 
resections was achieved to the same degree regardless of insurance status.  
Interestingly, no difference was observed in either the overall complication rate, grades of severity of 
intra- and postoperative complications nor in the majority of rates of individual complications recorded 
in the database, including rates of surgery-specific complications like anastomotic leakage. Only the 
rate of pneumonias and wound healing disorders were higher in patients with SI. This might reflect the 
increased rate of open surgical approaches with impaired postoperative pulmonary function or might 
be a sequalae of longer operation times. While patients with SI were operated more frequently by 
surgeons of lower hierarchical status, no correlation between the rates and severity of complications 
and the level of expertise of the operating surgeon was observed. This pleasant finding underlines the 
high quality of peri- and postoperative care for patients independent of insurance state and surgeons’ 
training.  
While our study allows to draw conclusions on eventual differences in short-term outcomes between 
patients with SI and PI, it also has several limitations: First, entry of data into the database is voluntary 
and therefore prone to bias due to the selection of hospitals which enter their data. A second potential 
bias could occur if patients with bad perioperative outcome are not entered in the database despite 
total anonymity. This would explain the overall low rates of complications recorded in the database. 
This could further be complicated if data entry is performed through time-limited hospital staff, i.e. 
residents and junior surgeons, which are inadequately trained for this purpose. The applied 
propensity-score matching algorithm can account for observed differences; however potential biases 
through unknown underlying factors might still be present while the omittance of patients might lead to 
a loss of power. Lastly, as the AQC database only collects and provides perioperative data of the 
hospitalization, no conclusion about long-term complications and oncological outcomes (i.e. Cancer-
specific survival or disease-free survival) can be drawn. Confirmation regarding similar oncological 
long-term outcomes among patients with SI and PI is therefore necessary.  
In summary, our data of a large population-based cohort of CRC patients receiving surgical resection 
in a European healthcare system show that the use of minimally invasive techniques was favored in 
patients with PI. Similarly, differences in blood loss and length of surgery likely reflect the higher levels 
of training in surgeons operating on patients with PI coverage. However, the quality of the oncological 
resection was not affected and only minor differences in postoperative complication rates observed.  
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CONCLUSION 
Insurance status does not affect perioperative outcomes in European patients with CRC in a 
significant manner and short-term oncological outcomes can be considered equal. 
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FIGURE & TABLE LEGENDS 
FIGURE 1: Flow diagram of database filtering & propensity score matching 
 
FIGURE 2: Surgical parameters of patients with private insurance (PI) and statutory insurance 
(SI). 
(A) A clear difference in the level of expertise of the operating surgeon was observed between patients 
with PI and SI (p ≤ 0.001) for both resection types. (B) Patients with PI were operated more frequently 
using minimally invasive techniques. Patients with SI undergoing a colon resection also suffered of a 
twice as high conversion rate as patients with PI (OR 2.44, p= 0.002). (C) Patients with SI had 
increased median operation times (C) as well as increased recorded blood loss (D) compared to 
patients with PI. (E) However, despite increased blood loss, longer operating times and more frequent 
open surgeries, the overall length of hospital stay was equal among for both colon and rectal 
resections. 
 
TABLE 1: Patient & tumor characteristics 
 
TABLE 2: Parameters of surgery 
 
TABLE 3: Complications 
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Original database extraction : 
n = 42689
(01.01.2007 – 31.12.2015)
1st interim database: 
n = 5343
Select patients with the main diagnoses (ICD 10-GM):
Malignant neoplasm of colon, rectosigmoid
junction or rectum
2nd interim database: 
n = 3624
Select patients according to surgical codes:
Partial/segmental/total colectomy or
rectal resection
3rd interim database: 
n = 2162
Exclusion of the following patients:
Non-elective, non-planned and non-stationary cases: 1363
Complication as reason for surgery: 18
Age missing or < 18 years: 1
Duration of surgery missing or < 60min : 36
Indication Insurance class missing: 26
Indication ASA Score missing: 18
Indication Gender missing: 0
PROPENSITY SCORE MATCHING
Statutory vs. Private Insurance
Based on: gender, age, ASA-score & 
location of primary tumor
Duplicates removed:
n = 28
4th interim database: 
n = 2134
Statutory = 1369 ; Private = 765
Statutory
Insurance
n = 765
Private
Insurance
n = 765
AB
C
D
E
Table 1: Patient & tumor characteristics 
  
Before matching 
(n=2134) 
 
 
After propensity  
score matching 
(n=1530) 
 
 
Statutory 
Insurance 
(n=1369) 
n= (%) 
Private 
Insurance 
(n=765) 
n= (%) 
Statutory 
Insurance 
(n=765) 
n= (%) 
Private 
Insurance 
(n=765) 
n= (%) 
 
Gender 
Male 809 (59.1%) 410 (53.6%) 408 (53.3%) 410 (53.6%) 
Female 560 (40.9%) 355 (46.4%) 357 (46.7%) 355 (46.4%) 
 p = 0.015 p = 0.959 
 
Age 
Median [IQR] 70 [61-78] 70 [62-77] 71 [62-78] 70 [62-77] 
 p = 0.232 p = 0.498 
 
ASA-score 
Score I 128 (9.3%) 95 (12.4%) 87 (11.4%) 95 (12.4%) 
Score II 680 (49.7%) 429 (56.1%) 428 (56.1%) 429 (56.1%) 
Score III 526 (38.4%) 234 (30.6%) 243 (31.8%) 234 (30.6%) 
Score IV 35 (2.6%) 7 (0.9%) 7 (0.9%) 7 (0.9%) 
 p ≤ 0.001 p = 0.908 
 
Location of tumor 
Colon  578 (42.2%) 398 (52.1%) 400 (52.3%) 398 (52.1%) 
Sigmoid  132 (9.6%) 43 (5.6%) 34 (4.4%) 43 (5.6%) 
Rectum 659 (48.1%) 324 (42.3%) 331 (43.3%) 324 (42.3%) 
 p ≤ 0.001 p = 0.574 
 
T-stage 
T1 243 (17.8%) 134 (17.5%) 129 (16.6%) 134 (17.5%) 
T2 270 (19.7%) 148 (19.4%) 155 (20.3%) 148 (19.4%) 
T3 679 (49.6%) 371 (48.5%) 393 (51.5%) 371 (48.5%) 
T4 148 (10.8%) 96 (12.5%) 75 (9.9%) 96 (12.5%) 
Tx/NA 28 (2.0%) 16 (2.1%) 13 (1.7%) 16 (2.1%) 
 p = 0.828 p = 0.228 
 
N-stage 
N0 825 (60.3%) 463 (60.5%) 474 (61.9%) 463 (60.5%) 
N1 323 (23.6%) 180 (23.5%) 177 (23.1%) 180 (23.5%) 
N2 199 (14.5%) 109 (14.3%) 103 (13.5%) 109 (14.3%) 
N3 3 (0.2%) 0 (0%) 2 (0.3%) 0 (0%) 
Nx/NA 19 (1.4%) 13 (1.7%) 9 (1.2%) 13 (1.7%) 
 p = 0.843 p = 0.638 
 
M-stage  
M0 893 (65.2%) 504 (65.8%) 506 (66.1%) 504 (65.8%) 
M1 155 (11.3%) 93 (12.2%) 77 (10.1%) 93 (12.2%) 
Mx/NA 321 (23.4%) 168 (22.0%) 182 (23.8%) 168 (22.0%) 
 p = 0.668 p = 0.361 
 
L-stage 
L0 607 (44.3%) 374 (48.9%) 334 (43.7%) 374 (48.9%) 
L1 263 (19.2%) 138 (18.0%) 131 (17.1%) 138 (18.0%) 
Lx/NA 499 (26.4%) 253 (33.1%) 300 (39.2%) 253 (33.1%) 
 p = 0.125 p = 0.720 
 
V-stage 
V0 669 (48.9%) 404 (52.8%) 362 (48.3%) 404 (52.8%) 
V1 186 (13.6%) 110 (14.4%) 97 (12.7%) 110 (14.4%) 
V2 3 (0.2%) 0 (0%) 2 (0.3%) 0 (0%) 
Vx/NA 511 (37.3%) 251 (32.8%) 304 (38.7%) 251 (32.8%) 
 p = 0.107 p = 0.447 
 
Histological grade 
G1 27 (2.0%) 19 (2.5%) 15 (2.0%) 19 (2.5%) 
G2 601 (43.9%) 380 (49.7%) 382 (49.9%) 380 (49.7%) 
G3 155 (11.3%) 110 (14.4%) 90 (11.8%) 110 (14.4%) 
Gx/NA 586 (42.8%) 256 (33.4%) 278 (36.3%) 256 (33.4%) 
 p ≤ 0.001 
 
p = 0.337 
Abbreviations: IQR = Interquartile Range 
 
 
Table 2: Parameters of surgery 
  
Colon resection 
 
 
Rectal resection 
 
Statutory 
Insurance 
n= (%) 
Private 
Insurance 
n= (%) 
Statutory 
Insurance 
n= (%) 
Private 
Insurance 
n= (%) 
 
Parameters of surgical technique 
 
Surgical technique 
Open surgery/not 
otherwise indicated 
317 (73.0%) 265 (60.1%) 196 (59.2%) 163 (50.3%) 
Minimally invasive 
(laparoscopic or 
robotic) surgery 
81 (18.7%) 149 (33.8%) 126 (38.1%) 142 (43.8%) 
Conversion from 
minimally invasive 
to open surgery 
36 (8.3%) 27 (6.1%) 9 (2.7%) 19 (5.9%) 
 p ≤ 0.001 
 
OR for MIS approach:  
1.79 (1.33-2.41), p ≤ 0.001 
 
OR for conversion:  
2.44 (1.34-4.51) p = 0.002 
p = 0.023 
 
OR for MIS approach:  
1.43 (1.04-1.97), p = 0.023 
 
OR for conversion:  
0.53 (0.20-1.29), p = 0.163 
 
Ileostomy formation 
Yes 15 (3.5%) 10 (2.3%) 85 (25.7%) 97 (29.9%) 
No 419 (96.5%) 431 (97.7%) 246 (74.3%) 227 (70.1%) 
 OR: 1.54 (0.63-3.88), p = 0.31 OR: 0.80 (0.56-1.15), p = 0.256 
 
Colostomy formation 
Yes 1 (0.2%) 1 (0.2%) 25 (7.6%) 24 (7.4%) 
No 433 (99.8%) 430 (99.8%) 306 (92.4%) 300 (92.6%) 
 OR: 1.01 (0.01-79.89), p = 1 OR: 1.02 (0.54-1.91), p = 1 
 
Parameters of oncological resection 
 
R-stage 
R0 407 (93.8%) 412 (93.4%) 313 (94.6%) 304 (93.8%) 
R1 10 (2.3%) 11 (2.5%) 12 (3.6%) 12 (3.7%) 
R2 6 (1.5%) 8 (1.8%) 1 (0.3%) 2 (0.6%) 
Rx/NA 11 (2.5%) 10 (2.3%) 5 (1.5%) 6 (1.9%) 
 p = 0.928 
 
OR for R+ resection:  
0.85 (0.40-1.77), p = 0.730 
p = 0.937 
 
OR for R+ resection:  
0.90 (0.38-2.10), p = 0.845 
 
Lymph Nodes removed 
Mean     
Median [IQR] 21 (16-28) 19 (16-27) 18 (14-23.75) 18 (14-25) 
NA 77 59 25 25 
 p = 0.447 p = 0.944 
 
Lymph Nodes invaded 
Mean 2.29 3.15 1.95 1.55 
Median [IQR] 0 (0-3) 1 (0-4) 0 (0-2) 0 (0-2) 
NA 156 144 45 75 
 p = 0.03 
 
p = 0.54 
Abbreviations: IQR = Interquartile Range ; NA = Data not available 
 
 
Table 3: Complications 
  
Colon resection 
 
 
Rectal resection 
 
Statutory 
Insurance 
n= (%) 
Private 
Insurance 
n= (%) 
Statutory 
Insurance 
n= (%) 
Private 
Insurance 
n= (%) 
 
Severity of intraoperative complication 
None 417 (96.5%) 429 (98.2%) 315 (96.6%) 298 (94.0%) 
Simple  8 (1.9%) 6 (1.4%) 5 (1.5%) 7 (2.2%) 
Intermediate  5 (1.2%) 2 (0.5%) 3 (0.9%) 3 (0.9%) 
Severe  2 (0.5%) 0 (0%) 3 (0.9%) 9 (2.8%) 
 p = 0.365 
 
p = 0.308 
 
 
Overall postoperative complication rate 
No complication 398 (91.7%) 406 (92.1%) 241 (72.8%) 244 (75.3%) 
Complication 36 (8.3%) 35 (7.9%) 90 (27.2%) 80 (24.7%) 
 p = 0.901 
OR: 1.04 (0.62-1.75) 
p = 0.477 
OR: 1.13 (0.79-1.62) 
 
Severity of postoperative complications according to Clavien-Dindo score 
Grade I 14 (38.9%) 10 (28.6%) 15 (16.7%) 21 (26.2%) 
Grade II 11 (30.6%) 16 (45.7%) 47 (52.2%) 31 (38.8%) 
Grade III 9 (25.1%) 8 (22.9%) 19 (21.1%) 20 (25%) 
Grade IV 2 (5.6%) 1 (2.9%) 6 (6.7%) 6 (7.5%) 
Grade V 0 (0%) 0 (0%) 3 (3.3%) 2 (2.5%) 
 p = 0.140 
 
p = 0.335 
 
Rates of specific postoperative complications  
Anastomotic failure 6 (1.4%) 5 (1.1%) 12 (3.6%) 11 (3.4%) 
p = 0.771 
OR: 1.22 (0.30-5.10) 
p = 0.499 
OR: 1.07 (0.42-2.72) 
Seroma 3 (0.7%) 2 (0.5%) 1 (0.3%) 0 (0%) 
p = 0.684 
OR: 1.52 (0.17-18.36) 
p = 1 
OR: Inf (0.02-Inf) 
Hematoma 2 (0.5%) 0 (0%) 1 (0.3%) 1 (0.3%) 
p = 0.245 
OR: Inf (0.19-Inf) 
p = 1 
OR: 0.97 (0.01-77.02) 
Fascia Dehiscence 0 (0%) 0 (0%) 1 (0.3%) 0 (0%) 
p = 1 
OR: 0 (0.00-Inf) 
p = 1 
OR: Inf (0.02-Inf) 
Superficial Wound 
Infection 
1 (0.2%) 0 (0%) 0 (0%) 0 (0%) 
p = 0.496 
OR: Inf (0.02-Inf) 
p = 1 
OR: 0 (0.00-Inf) 
Intraabdominal 
Abscess 
2 (0.5%) 1 (0.2%) 3 (0.9%) 4 (1.2%) 
p = 0.621 
OR: 2.03 (0.10-120.36) 
p = 0.72 
OR: 0.73 (0.10-4.36) 
Secondary 
Haemorrhage 
2 (0.5%) 6 (1.4%) 2 (0.6%) 0 (0%) 
p = 0.286 
OR: 0.33 (0.03-1.89) 
p = 0.499 
OR: Inf (0.18-Inf) 
Wound Healing 
Disorders 
15 (3.5%) 3 (0.7%) 12 (3.6%) 13 (4.0%) 
p = 0.003 
OR: 5.21 (1.46-28.30) 
p = 0.840 
OR: 0.90 (0.36-2.17) 
Urinary Tract 
Infection 
8 (1.8%) 10 (2.3%) 10 (3.0%) 9 (2.8%) 
p = 0.812 
OR: 0 (0.27-2.30) 
p = 1 
OR: 1.09 (0.39-3.07) 
Paralytic Ileus 12 (2.8%) 6 (1.4%) 10 (3%) 13 (4%) 
p = 0.159 
OR: 1.05 (0.70-6.73) 
p = 0.530 
OR: 0.74 (0.28-1.87) 
Pneumonia 8 (1.8%) 1 (0.2%) 6 (1.8%) 3 (0.9%) 
p = 0.019 
OR: 8.24 (1.09-366) 
p = 0.505 
OR: 1.97 (0.41-12.29) 
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Point 1: Information AQC database 
The AQC (Swiss association for quality management in surgery;Arbeitsgemeinschaft für 
Qualitätssicherung in der Chirurgie, Switzerland) is maintaining a prospective database on patient and 
operative data in public Swiss hospitals. Today, more than 50 surgical departments are reporting their 
data to the AQC, making the AQC the largest national database for the assessment of surgical quality. 
Extracts of the database can be received freely on demand for research projects.  
 
Homepage:  http://www.aqc.ch/ 
Email:   aqc@aqc.ch 
 
The data imposed in the database can be reviewed under the following link (German, French & 
Italian): 
http://www.aqc.ch/Willkommen-bei-der-AQC/Datenerfassung.aspx  
Point 2: ICD-10-GM Codes for database filtering  
The following ICD-10-GM Codes (Version 2016) were used for Identification of patients diagnosed with 
malignant colorectal carcinoma: 
 
ICD-10 Code Diagnosis 
C18.0-9 Malignant neoplasm of colon 
C19 Malignant neoplasm of recto-sigmoid junction 
C20 Malignant neoplasm of rectum 
 
Final database filtering and application of codes were done on the 30th of April 2017.  
 
The current ICD-10-GM Codes (2016 version) were retrieved from the Swiss federal office of statistics, 
medical section, under the following links: 
 
• https://www.bfs.admin.ch/bfs/de/home/statistiken/gesundheit/nomenklaturen/medkk/instrumen
te-medizinische-kodierung.html#par_headline_1153027117 
• http://www.dimdi.de/static/de/klassi/icd-10-
gm/kodesuche/onlinefassungen/htmlgm2016/index.htm 
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Point 3: Surgical CHOP codes for database filtering  
All medical treatments, including surgical interventions, of in-hospital patients in Switzerland are coded 
according to guidelines of the Swiss federal office of Statistics (CHOP-Codes). These revised and up-
to date CHOP Codes are issued annually and can be retrieved online: 
• https://www.bfs.admin.ch/bfs/de/home/statistiken/gesundheit/nomenklaturen/medkk/instrumen
te-medizinische-kodierung.assetdetail.483959.html 
 
For our study, the 2017 CHOP Codes were applied (issued on the 29th of June 2016) and final filtering 
according to the codes was done on the 30th of April 2017.  
 
The following CHOP Codes (2017 version) were used for Identification of patients undergoing 
segmental/total colectomy or rectal resection: 
 
CHOP Code Treatment 
45.7 Partial/segmental colectomy, including hemicolectomy left/right 
45.8 Total colectomy 
48.5 Abdominoperineal rectal resection 
48.6 Other rectal resection 
Point 4: Surgical CHOP codes for assessment of stoma formation  
CHOP Code Treatment 
46.1 Colostomy 
46.2/46.3 Ileostomy 
Point 5/Figure: Distribution of propensity scores 
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Point 6: Hierarchical positions in swiss surgical departments and corresponding 
English expressions used in the manuscript 
 
Hierarchical position in swiss surgical 
departments (German original denotation) 
 
 
Corresponding English expression 
used in the manuscript 
 
Assistenzarzt 
 
 
Resident 
 
Oberarzt 
 
 
Junior attending surgeon 
 
Leitender (Ober-)Arzt 
 
 
Senior attending surgeon 
 
Chefarzt 
 
 
Chief of surgical department 
 
Chirurg in Privatpraxis / Belegarzt 
 
 
Surgeon in private practice 
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Point 7: Severity of intraoperative complications 
Classification according to the guidelines of the Swiss society of anaesthesiology & resuscitation: 
http://www.sgar-ssar.ch/ 
Severity of intraoperative complications 
Simple  Small temporary problem, easily controllable and/or self-limiting. 
 
Intermediate  Intermediate problem, necessitates unplanned intervention and/or persisting 
despite initial treatment. 
 
Severe  Severe, possible life-threatening problem, not responding on initial treatment and 
resulting in significant change in treatment-plan and/or necessitating follow up 
intervention/operation. 
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Point 8/Table: Rates of specific intraoperative organ injures 
Table: Intraoperative complications/organ injuries 
  
Colon resection 
 
 
Rectal resection 
 
Statutory 
Insurance 
n= (%) 
Private 
Insurance 
n= (%) 
Statutory 
Insurance 
n= (%) 
Private 
Insurance 
n= (%) 
 
Intraoperative complications / organ injuries 
Biliary tract 0 (0%) 0 (0%) 0 (0%) 1 (0.3%) 
p = 1 
OR: 0 (0.00-Inf) 
p = 0.494 
OR: 0.00 (0.00-38.17) 
Liver 0 (0%) 1 (0.2%) 0 (0%) 0 (0%) 
 p = 1 
OR: Inf (0.02- Inf) 
p = 1 
OR: 0 (0.00-Inf) 
Artery 2 (0.5%) 0 (0%) 1 (0.3%) 3 (0.9%) 
 p = 0.245 
OR: 0 (0.00-5.23) 
p = 0.368 
OR: 3.07 (0.24-162.25) 
Vein 2 (0.5%) 0 (0%) 1 (0.3%) 1 (0.3%) 
 p = 0.245 
OR: 0 (0.00-5.23) 
p = 1 
OR: 1.02 (0.01-80.39) 
Stomach/small 
intestine 
3 (0.7%) 0 (0%) 2 (0.6%) 0 (0%) 
 p = 0.121 
OR: 0 (0.00-2.37) 
p = 0.499 
OR: 0.00 (0.00-5.43) 
Colon/rectum 1 (0.2%) 0 (0%) 1 (0.3%) 0 (0%) 
 p = 0.496 
OR: 0 (0.00-38.38) 
p = 1 
OR: 0.00 (0.00-39.84) 
Spleen 1 (0.2%) 3 (0.7%) 1 (0.3%) 2 (0.6%) 
 p = 0.624 
OR: 2.96 (0.23-155.92) 
p = 0.620 
OR: 2.04 (0.10-121.20) 
Ureter 2 (0.5%) 0 (0%) 0 (0%) 2 (0.6%) 
 p = 0.245 
OR: 0 (0.00-5.23) 
p = 0.244 
OR: Inf (0.19-Inf) 
Urinary bladder 0 (0%) 1 (0.2%) 1 (0.3%) 0 (0%) 
 p = 1 
OR: Inf (0.02- Inf) 
p = 1 
OR: 0.00 (0.00-39.84) 
Uterus/annexes 0 (0%) 0 (0%) 0 (0%) 1 (0.3%) 
 p = 1 
OR: 0 (0.00-Inf) 
p = 0.494 
OR: 0.00 (0.00-38.17) 
Kidney 0 (0%) 0 (0%) 1 (0.3%) 0 (0%) 
 p = 1 
OR: 0 (0.00-Inf) 
p = 1 
OR: 0.00 (0.00-39.84) 
Unspecified 
intraoperative 
complication 
1 (0.2%) 1 (0.2%) 1 (0.3%) 2 (0.6%) 
p = 1 
OR: 0.98 (0.01-77.38) 
p = 0.620 
OR: 2.04 (0.10-121.20) 
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Point 9/Table: Rate of specific postoperative complications 
Table: Specific postoperative complications 
  
Colon resection 
 
 
Rectal resection 
Parameter 
Statutory 
Insurance 
n= (%) 
Private 
Insurance 
n= (%) 
Statutory 
Insurance 
n= (%) 
Private 
Insurance 
n= (%) 
 
Cardiovascular  
Myocardial 
Infarction 
0 (0%) 2 (0.5%) 3 (0.9%) 0 (0%) 
p = 0.499 
OR: 0 (0.00-5.40) 
p = 0.248 
OR: Inf (0.40-Inf) 
Arrhythmia 5 (1.2%) 3 (0.7%) 3 (0.9%) 1 (0.3%) 
p = 0.502 
OR: 1.7 (0.32-11.02) 
p = 0.623 
OR: 2.95 (0.23-155.43) 
Low Output  0 (0%) 0 (0%) 0 (0%) 2 (0.6%) 
p = 1 
OR: 0 (0.00-Inf) 
p = 0.244 
OR: 0.00 (0.00-5.20) 
Deep Vein 
Thrombosis 
0 (0%) 0 (0%) 1 (0.3%) 0 (0%) 
p = 1 
OR: 0 (0.00-Inf) 
p = 1 
OR: Inf (0.02-Inf) 
 
Pulmonary  
Pulmonary failure 2 (0.5%) 3 (0.7%) 2 (0.6%) 1 (0.3%) 
p = 1 
OR: 0.67 (0.05-5.93) 
p = 1 
OR: 1.96 (0.10-116.11) 
Pulmonary 
Embolus 
1 (0.2%) 0 (0%) 1 (0.3%) 0 (0%) 
p = 0.496 
OR: Inf (0.02-Inf) 
p = 1 
OR: Inf (0.02-Inf) 
Pleural Effusion 0 (0%) 1 (0.2%) 2 (0.6%) 1 (0.3%) 
p = 1 
OR: 0 (0.00-39.62) 
p = 1 
OR: 1.96 (0.10-116.11) 
Pneumothorax 0 (0%) 2 (0.5%) 0 (0%) 0 (0%) 
p = 0.499 
OR: 0 (0.00-5.40) 
p = 1 
OR: 0 (0.00-Inf) 
Atelectasis 0 (0%) 1 (0.2%) 0 (0%) 0 (0%) 
p = 1 
OR: 0 (0.00-39.62) 
p = 1 
OR: 0 (0.00-Inf) 
 
Gastrointestinal  
Gastrointestinal 
Bleeding 
1 (0.2%) 2 (0.5%) 2 (0.6%) 0 (0%) 
p = 1 
OR: 0.50 (0.00-9.77) 
p = 0.499 
OR: Inf (0.18-Inf) 
Small bowel 
obstruction 
0 (0%) 3 (0.7%) 2 (0.6%) 8 (2.5%) 
p = 0.249 
OR: 0 (0.00-2.45) 
p = 0.060 
OR: 0.24 (0.02-1.21) 
Liver Failure 0 (0%) 1 (0.2%) 0 (0%) 0 (0%) 
p = 1 
OR: 0 (0.00-39.62) 
p = 1 
OR: 0 (0.00-Inf) 
 
Urogenital  
Renal failure 0 (0%) 3 (0.7%) 1 (0.3%) 4 (1.2%) 
p = 0.249 
OR: 0 (0.00-2.45) 
p = 0.212 
OR: 0.24 (0.00-2.47) 
Electrolyte 
Disbalance 
3 (0.7%) 0 (0%) 0 (0%) 2 (0.6%) 
p = 0.121 
OR: Inf (0.42-Inf) 
p = 0.244 
OR: 0.00 (0.00-5.20) 
Bladder 
Tamponade 
0 (0%) 1 (0.2%) 1 (0.3%) 1 (0.3%) 
p = 1 
OR: 0 (0.00-39.62) 
p = 1 
OR: 0.97 (0.01-77.02) 
Urosepsis 3 (0.7%) 0 (0%) 0 (0%) 1 (0.3%) 
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p = 0.121 
OR: Inf (0.42-Inf) 
p = 0.494 
OR: 0.00 (0.00-38.17) 
Urinary Fistula 1 (0.2%) 0 (0%) 0 (0%) 1 (0.3%) 
p = 0.496 
OR: Inf (0.02-Inf) 
p = 0.494 
OR: 0.00 (0.00-38.17) 
Urinary Retention 3 (0.7%) 3 (0.7%) 13 (3.9%) 5 (1.5%) 
p = 1 
OR: 1.01 (0.13-7.63) 
p = 0.092 
OR: 2.60 (0.85-9.44) 
 
Infectious & Others  
Peritonitis 0 (0%) 0 (0%) 2 (0.6%) 1 (0.3%) 
p = 1 
OR: 0 (0.00-Inf) 
p = 1 
OR: 1.96 (0.10-116.11) 
Sepsis 0 (0%) 3 (0.7%) 3 (0.9%) 2 (0.6%) 
p = 0.249 
OR: 0 (0.00-2.45) 
p = 1 
OR: 1.47 (0.16-17.72) 
Multi Organ Failure 0 (0%) 2 (0.5%) 0 (0%) 0 (0%) 
p = 0.499 
OR: 0 (0.00-5.40) 
p = 1 
OR: 0 (0.00-Inf) 
Coagulation 
Disorder 
0 (0%) 0 (0%) 1 (0.3%) 0 (0%) 
p = 1 
OR: 0 (0.00-Inf) 
p = 1 
OR: Inf (0.02-Inf) 
Anaesthesia related 
nerve pressure 
lesion  
0 (0%) 1 (0.2%) 1 (0.3%) 3 (0.9%) 
p = 1 
OR: 0 (0.00-39.62) 
p = 0.368 
OR: 0.32 (0.00-4.06) 
Psychosis 1 (0.2%) 1 (0.2%) 1 (0.3%) 0 (0%) 
p = 1 
OR: 1.01 (0.01-79.89) 
p = 1 
OR: Inf (0.02-Inf) 
Delirium 0 (0%) 2 (0.5%) 1 (0.3%) 2 (0.5%) 
p = 0.499 
OR: 0 (0.00-5.40) 
p = 0.620 
OR: 0.48 (0.00-9.42) 
Allergic reaction 0 (0%) 0 (0%) 1 (0.3%) 1 (0.3%) 
p = 1 
OR: 0 (0.00-Inf) 
p = 1 
OR: 0.97 (0.01-77.02) 
Other, not specified 24 (5.5%) 14 (3.2%) 37 (11.2%) 37 (11.2%) 
p = 0.09 
OR: 1.78 (0.87-3.78) 
p = 1 
OR: 0.97 (0.58-1.63) 
 
Surgery-related complications 
Douglas Abscess 0 (0%) 0 (0%) 0 (0%) 2 (0.6%) 
p = 1 
OR: 0 (0.00-Inf) 
p = 0.244 
OR: 0.00 (0.00-5.20) 
Anastomotic 
Stricture 
0 (0%) 1 (0.2%) 1 (0.3%) 1 (0.3%) 
p = 1 
OR: 0 (0.00-39.62) 
p = 1 
OR: 0.97 (0.01-77.02) 
Ostomy-related 
Complications 
0 (0%) 0 (0%) 3 (0.9%) 2 (0.6%) 
p = 1 
OR: 0 (0.00-Inf) 
p = 1 
OR: 1.47 (0.16-17.72) 
Small bowel Fistula 0 (0%) 0 (0%) 1 (0.3%) 0 (0%) 
p = 1 
OR: 0 (0.00-Inf) 
p = 1 
OR: Inf (0.02-Inf) 
Large bowel Fistula 0 (0%) 0 (0%) 0 (0%) 1 (0.3%) 
p = 1 
OR: 0 (0.00-Inf) 
p = 0.494 
OR: 0.00 (0.00-38.17) 
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Point 10: Session Info R-Studio 
> sessionInfo() 
R version 3.4.3 (2017-11-30) 
Platform: x86_64-w64-mingw32/x64 (64-bit) 
Running under: Windows >= 8 x64 (build 9200) 
 
Matrix products: default 
 
locale: 
[1] LC_COLLATE=German_Switzerland.1252  LC_CTYPE=German_Switzerland.1252    
LC_MONETARY=German_Switzerland.1252 LC_NUMERIC=C                        
[5] LC_TIME=German_Switzerland.1252     
 
attached base packages: 
[1] stats     graphics  grDevices utils     datasets  methods   base      
 
other attached packages: 
 [1] bindrcpp_0.2.2      gridExtra_2.3       ggpubr_0.1.7        magrittr_1.5        ggsci_2.9           ggbeeswarm_0.6.0    
RColorBrewer_1.1-2  
 [8] ReporteRs_0.8.10    ReporteRsjars_0.0.4 rJava_0.9-10        forcats_0.3.0       dplyr_0.7.6         ggplot2_3.0.0       
 
loaded via a namespace (and not attached): 
 [1] beeswarm_0.2.3    tidyselect_0.2.4  purrr_0.2.5       colorspace_1.3-2  htmltools_0.3.6   yaml_2.1.19       
base64enc_0.1-3   rlang_0.2.1       
 [9] R.oo_1.22.0       pillar_1.3.0      later_0.7.3       glue_1.3.0        withr_2.1.2       R.utils_2.6.0     gdtools_0.1.7     
uuid_0.1-2        
[17] bindr_0.1.1       plyr_1.8.4        munsell_0.5.0     gtable_0.2.0      R.methodsS3_1.7.1 zip_1.0.0         labeling_0.3      
knitr_1.20        
[25] httpuv_1.4.5      vipor_0.4.5       Rcpp_0.12.17      xtable_1.8-2      scales_0.5.0      promises_1.0.1    mime_0.5          
png_0.1-7         
[33] digest_0.6.15     shiny_1.1.0       cowplot_0.9.3     grid_3.4.3        tools_3.4.3       lazyeval_0.2.1    tibble_1.4.2      
crayon_1.3.4      
[41] pkgconfig_2.0.1   xml2_1.2.0        rvg_0.1.9         assertthat_0.2.0  officer_0.3.1     rstudioapi_0.7    R6_2.2.2          
compiler_3.4.3    
 
